These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14966121)

  • 1. Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.
    Wang Q; Udayakumar TS; Vasaitis TS; Brodie AM; Fondell JD
    J Biol Chem; 2004 Apr; 279(17):17319-28. PubMed ID: 14966121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
    Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
    Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.
    Gregory CW; Fei X; Ponguta LA; He B; Bill HM; French FS; Wilson EM
    J Biol Chem; 2004 Feb; 279(8):7119-30. PubMed ID: 14662770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor interacts with a novel MYST protein, HBO1.
    Sharma M; Zarnegar M; Li X; Lim B; Sun Z
    J Biol Chem; 2000 Nov; 275(45):35200-8. PubMed ID: 10930412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells.
    Wang L; Lin HK; Hu YC; Xie S; Yang L; Chang C
    J Biol Chem; 2004 Jul; 279(31):32444-52. PubMed ID: 15178691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.
    Ueda T; Bruchovsky N; Sadar MD
    J Biol Chem; 2002 Mar; 277(9):7076-85. PubMed ID: 11751884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
    Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
    Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells.
    Mayeur GL; Kung WJ; Martinez A; Izumiya C; Chen DJ; Kung HJ
    J Biol Chem; 2005 Mar; 280(11):10827-33. PubMed ID: 15640154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.
    Buchanan G; Need EF; Barrett JM; Bianco-Miotto T; Thompson VC; Butler LM; Marshall VR; Tilley WD; Coetzee GA
    Mol Cell Endocrinol; 2011 Aug; 342(1-2):20-31. PubMed ID: 21664238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway.
    Rigas AC; Ozanne DM; Neal DE; Robson CN
    J Biol Chem; 2003 Nov; 278(46):46087-93. PubMed ID: 12958311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
    Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
    J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
    Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
    J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptor.
    Shatkina L; Mink S; Rogatsch H; Klocker H; Langer G; Nestl A; Cato AC
    Mol Cell Biol; 2003 Oct; 23(20):7189-97. PubMed ID: 14517289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
    Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
    Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor.
    Verras M; Sun Z
    Mol Endocrinol; 2005 Feb; 19(2):391-8. PubMed ID: 15514031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collocation of androgen receptor gene mutations in prostate cancer.
    Buchanan G; Greenberg NM; Scher HI; Harris JM; Marshall VR; Tilley WD
    Clin Cancer Res; 2001 May; 7(5):1273-81. PubMed ID: 11350894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice.
    Albertelli MA; O'Mahony OA; Brogley M; Tosoian J; Steinkamp M; Daignault S; Wojno K; Robins DM
    Hum Mol Genet; 2008 Jan; 17(1):98-110. PubMed ID: 17906287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.